BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32128811)

  • 1. BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson's disease model.
    Kataura T; Saiki S; Ishikawa KI; Akamatsu W; Sasazawa Y; Hattori N; Imoto M
    J Neurochem; 2020 Oct; 155(1):81-97. PubMed ID: 32128811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
    Pan PK; Qiao LY; Wen XN
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling.
    Lu Q; Gouda NA; Quan G; Nada H; Elkamhawy A; Lee D; Lee CH; Cho J; Lee K
    Eur J Med Chem; 2022 Nov; 242():114692. PubMed ID: 36029560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20C, a bibenzyl compound isolated from Gastrodia elata, protects PC12 cells against rotenone-induced apoptosis via activation of the Nrf2/ARE/HO-1 signaling pathway.
    Huang JY; Yuan YH; Yan JQ; Wang YN; Chu SF; Zhu CG; Guo QL; Shi JG; Chen NH
    Acta Pharmacol Sin; 2016 Jun; 37(6):731-40. PubMed ID: 27180985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
    de Siqueira EA; Magalhães EP; de Assis ALC; Sampaio TL; Lima DB; Marinho MM; Martins AMC; de Andrade GM; de Barros Viana GS
    Neurochem Res; 2023 Jan; 48(1):250-262. PubMed ID: 36066698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 regulating PI3K-Nrf2 signaling plays a significant role in bibenzyl compound 20C-mediated neuroprotection against rotenone-induced oxidative insult.
    Zhang XL; Yuan YH; Shao QH; Wang ZZ; Zhu CG; Shi JG; Ma KL; Yan X; Chen NH
    Toxicol Lett; 2017 Apr; 271():74-83. PubMed ID: 28245986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effect of Natural Alkaloid Fangchinoline Against Oxidative Glutamate Toxicity: Involvement of Keap1-Nrf2 Axis Regulation.
    Bao F; Tao L; Zhang H
    Cell Mol Neurobiol; 2019 Nov; 39(8):1177-1186. PubMed ID: 31270710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara.
    Lee J; Song K; Huh E; Oh MS; Kim YS
    Redox Biol; 2018 Sep; 18():6-15. PubMed ID: 29890337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
    Abdelsalam RM; Safar MM
    J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxytyrosol butyrate inhibits 6-OHDA-induced apoptosis through activation of the Nrf2/HO-1 axis in SH-SY5Y cells.
    Funakohi-Tago M; Sakata T; Fujiwara S; Sakakura A; Sugai T; Tago K; Tamura H
    Eur J Pharmacol; 2018 Sep; 834():246-256. PubMed ID: 30053409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
    Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
    J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Pyrazolo[3,4-
    Lee JA; Kwon YW; Kim HR; Shin N; Son HJ; Cheong CS; Kim DJ; Hwang O
    Mol Cells; 2022 Mar; 45(3):134-147. PubMed ID: 34887364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT/Nrf2 pathway.
    Katila N; Bhurtel S; Park PH; Choi DY
    Neurochem Int; 2021 Sep; 148():105120. PubMed ID: 34197898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway.
    Ren J; Yuan L; Wang W; Zhang M; Wang Q; Li S; Zhang L; Hu K
    Toxicol Appl Pharmacol; 2019 Sep; 378():114617. PubMed ID: 31176653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline.
    Koriyama Y; Nakayama Y; Matsugo S; Kato S
    Brain Res; 2013 Mar; 1499():145-57. PubMed ID: 23295186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroprotective effect of ginsenoside Re on drosophila model of Parkinson's disease].
    Xu Y; Meng X; Zhao WX; Liu DG; Zhu JG; Yao R; Yao JC; Zhang GM
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1927-1935. PubMed ID: 37282969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Propargyl Caffeate Amide (PACA) Potentiates Nerve Growth Factor (NGF)-Induced Neurite Outgrowth and Attenuates 6-Hydroxydopamine (6-OHDA)-Induced Toxicity by Activating the Nrf2/HO-1 Pathway.
    Yang C; Zhao J; Cheng Y; Le XC; Rong J
    ACS Chem Neurosci; 2015 Sep; 6(9):1560-9. PubMed ID: 26147318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 inhibits 6-hydroxydopamine-mediated endoplasmic reticulum stress-induced apoptosis via regulation of heme oxygenase-1 and Nrf2 expression in PC12 cells.
    Kim Y; Li E; Park S
    Int J Neurosci; 2012 Nov; 122(11):641-9. PubMed ID: 22703470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
    Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M
    Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.